Tafasitamab (Monjuvi)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tafasitamab (Monjuvi), covering 2025-12-10 to 2025-12-18. Get the full timeline:
Most recent: Clinical Trial Update: Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]